Andre Badalyan

ALSA Ventures is a life science venture capital investor, focused on early stage novel therapeutics. With a strong operations background in drug development, our team seeks to bring together outstanding entrepreneurs and world class academic researchers to help bring promising new treatments to market. We invest across a wide spectrum of therapeutic areas, targeting high unmet need with impactful outcomes for patients and society at large.

We invest for the long-term in listed companies with a significant European presence and the foundations to generate multiple years of attractive risk-adjusted returns. We believe our private equity and corporate experience, owning and running businesses, provides us with a competitive advantage to conduct in depth due diligence, understand companies thoroughly, learn from management teams, and embrace long-term thinking to deliver sustainable value to our clients. Learn more at www.spinecap.com

This is a catchall company for the doers, the thinkers, and the innovators.

Vantage Biosciences is a UK-based clinical stage biotechnology company targeting the root cause of vision loss resulting from diabetes – the neuroinflammatory insult that precedes microangiopathy and leads to degeneration of the neurovascular unit of the eye. Our mission is to enable patient access to disease modifying therapy for diabetic eye disease by developing drugs that intervene at the earliest point of disease biology.

ALSA Ventures is a life science venture capital investor, focused on early stage novel therapeutics. With a strong operations background in drug development, our team seeks to bring together outstanding entrepreneurs and world class academic researchers to help bring promising new treatments to market. We invest across a wide spectrum of therapeutic areas, targeting high unmet need with impactful outcomes for patients and society at large.

We invest for the long-term in listed companies with a significant European presence and the foundations to generate multiple years of attractive risk-adjusted returns. We believe our private equity and corporate experience, owning and running businesses, provides us with a competitive advantage to conduct in depth due diligence, understand companies thoroughly, learn from management teams, and embrace long-term thinking to deliver sustainable value to our clients. Learn more at www.spinecap.com

This is a catchall company for the doers, the thinkers, and the innovators.

We are a #Cambridge, UK based #healthcare & #lifesciences investor and venture builder developing #startups that are built to succeed globally.